Rugby Antihistamine and Decongestant Tablets Recalled for Failed Dissolution
Dr. Reddy's Laboratories is recalling Rugby brand antihistamine and nasal decongestant tablets nationwide due to failed dissolution specifications. The affected product is NDC 0536-1242-07, Lot #AC2106452F with expiration date 3/31/2023.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: This is an FDA Class III recall with no reported illnesses, injuries, or deaths. The hazard is a manufacturing specification failure (dissolution) that does not present an immediate, direct risk of harm. Class III recalls are typically scored as 1 or 2, and without evidence of actual adverse events, this falls into the Low category.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling Rugby Antihistamine and Nasal Decongestant Extended-Release Tablets (Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg) due to failed dissolution specifications. The affected product is packaged in boxes of 30 tablets with NDC 0536-1242-07.
Lot #AC2106452F (expiration date 3/31/2023) has been identified as failing to meet dissolution specifications. A total of 2,352 boxes were distributed nationwide in the USA by Rugby Laboratories, located in Livonia, Michigan. The product was manufactured in India.
Consumers in possession of this medication should stop use immediately and consult with their pharmacist or physician regarding this recall. The product should not be used until further guidance is provided by the manufacturer or FDA.
The recalled product
- Product
- Rugby, Antihistamine and Nasal Decongestant, Fexofenadine HCl 60mg and Pseudoephedrine HCl 120mg, Extended-Release Tablets USP, 30 Tablets per box, NDC 0536-1242-07, Distributed by: Rugby Laboratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI, 49152, Made in India.
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Hazard
- dissolution-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AC2106452F
- Exp. 3/31/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27